VALIDATION OF CNS-IPI AND CORRELATION WITH CELL OF ORIGIN PROFILE IN A RETROSPECTIVE SERIES OF DLBCL PATIENTS TREATED WITH R-CHOP IN A SINGLE INSTITUTION

被引：0
|
作者：
Castellino, A.
Novo, M.
Chiappella, A.
Ciochetto, C.
Vittone, F.
Botto, B.
Cavallo, F.
Orsucci, L.
Boccomini, C.
Evangelista, A.
Ghione, P.
Nicolosi, M.
Santambrogio, E.
Ciccone, G.
Novero, D.
Vitolo, U.
机构：
[1] Univ Torino, Ematol, Turin, Italy
[2] AOU Citta Salute & Sci, Anat Patol, Turin, Italy
[3] AOU Citta Salute & Sci, CPO, Epidemiol Clin, Turin, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P150
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [21] Both discordant and concordant bone marrow (BM) involvement predict for a poorer outcome independent of the IPI in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP
    Sehn, Laurie H.
    Chhanabhai, Mukesh
    Singh, Suman
    Saville, Wayne
    Matso, Dan
    Spinelli, John J.
    Connors, Joseph M.
    Gascoyne, Randy D.
    BLOOD, 2007, 110 (11) : 466A - 466A
  • [22] The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Wei, Xiaolei
    Hao, Xiaoxiao
    Zhou, Lizhi
    Wei, Qi
    Zhang, Yuankun
    Huang, Weimin
    Song, Jialin
    Feng, Ru
    Wei, Yongqiang
    SCIENTIFIC REPORTS, 2017, 7
  • [23] CNS relapse in DLBCL patients below 60 years treated with R-ACVBP, R-CHOEP, or R-CHOP: A joint analysis of LYSA and GLA/DSHNHL.
    Thieblemont, Catherine
    Altmann, Bettina
    Casasnovas, Olivier
    Frontzek, Fabian
    Morschhauser, Franck
    Oberic, Lucie
    Poeschel, Viola
    Fitoussi, Olivier
    Renaud, Loic
    Lenz, Georg
    Mounier, Nicolas
    Rosenwald, Andreas
    Ott, German
    Molina, Thierry
    Parrens, Marie
    Chartier, Loic
    Ziepert, Marita
    Tilly, Herve
    Schmitz, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Xiaolei Wei
    Xiaoxiao Hao
    Lizhi Zhou
    Qi Wei
    Yuankun Zhang
    Weimin Huang
    Jialin Song
    Ru Feng
    Yongqiang Wei
    Scientific Reports, 7
  • [25] The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
    Sehn, Laurie H.
    Berry, Brian
    Chhanabhai, Mukesh
    Fitzgerald, Catherine
    Gill, Karamjit
    Hoskins, Paul
    Klasa, Richard
    Savage, Kerry J.
    Shenkier, Tamara
    Sutherland, Judy
    Gascoyne, Randy D.
    Connors, Joseph M.
    BLOOD, 2007, 109 (05) : 1857 - 1861
  • [26] CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
    Schmitz, Norbert
    Zeynalova, Samira
    Nickelsen, Maike
    Kansara, Roopesh
    Villa, Diego
    Sehn, Laurie H.
    Glass, Bertram
    Scott, David W.
    Gascoyne, Randy D.
    Connors, Joseph M.
    Ziepert, Marita
    Pfreundschuh, Michael
    Loeffler, Markus
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) : 3150 - +
  • [27] A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution
    Huang, Jia-Jia
    Xia, Yi
    Wang, Yu
    Liu, Pan-Pan
    Bi, Xi-Wen
    Sun, Peng
    Lin, Tong-Yu
    Jiang, Wen-Qi
    Li, Zhi-Ming
    ONCOTARGET, 2016, 7 (27) : 41242 - 41250
  • [28] Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience
    Soomar, S. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S777 - S777
  • [29] REAL-TIME CELL-OF-ORIGIN SUBTYPE IDENTIFICATION BY GENE EXPRESSION PROFILE IN THE PHASE 3 ROBUST TRIAL OF LENALIDOMIDE plus R-CHOP VS PLACEBO plus R-CHOP IN PREVIOUSLY UNTREATED ABC-TYPE DLBCL
    Vitolo, U.
    Chiappella, A.
    Witzig, T. E.
    Spina, M.
    Gascoyne, R. D.
    Zhang, L.
    Flament, J.
    Repici, J.
    Conlin, E.
    Delissio, K.
    Nowakowski, G. S.
    HAEMATOLOGICA, 2016, 101 : 392 - 392
  • [30] Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India
    Gogia, Ajay
    Nair, Sukesh
    Arora, Shalabh
    Kumar, Lalit
    Sharma, Atul
    Gupta, Ritu
    Biswas, Ahitagni
    Mallick, Saumyaranjan
    FRONTIERS IN ONCOLOGY, 2021, 11
12345